| Literature DB >> 35886817 |
Nantipat Chimkhan1, Sutticha Na-Ranong Thammasittirong1,2, Sittiruk Roytrakul3, Sucheewin Krobthong4, Anon Thammasittirong1,2.
Abstract
Silver/silver chloride nanoparticles (Ag/AgCl NPs) are an alternative approach to control the larvae of Aedes aegypti, a vector of mosquito-borne diseases. However, the molecular mechanisms of Ag/AgCl NPs to A. aegypti have not been reported. In this work, Ag/AgCl NPs were synthesized using supernatant, mixed toxins from Bacillus thuringiensis subsp. israelensis (Bti), and heterologously expressed Cry4Aa and Cry4Ba toxins. The images from scanning electron microscopy revealed that the Ag/AgCl NPs were spherical in shape with a size range of 25-100 nm. The larvicidal activity against A. aegypti larvae revealed that the Ag/AgCl NPs synthesized using the supernatant of Bti exhibited higher toxicity (LC50 = 0.133 μg/mL) than the Ag/AgCl NPs synthesized using insecticidal proteins (LC50 = 0.148-0.217 μg/mL). The proteomic response to Ag/AgCl NPs synthesized using the supernatant of Bti in A. aegypti larvae was compared to the ddH2O-treated control. Two-dimensional gel electrophoresis analysis revealed 110 differentially expressed proteins, of which 15 were selected for identification using mass spectrometry. Six upregulated proteins (myosin I heavy chain, heat shock protein 70, the F0F1-type ATP synthase beta subunit, methyltransferase, protein kinase, and condensin complex subunit 3) that responded to Ag/AgCl NP treatment in A. aegypti were reported for NP treatments in different organisms. These results suggested that possible mechanisms of action of Ag/AgCl NPs on A. aegypti larvae are: mitochondrial dysfunction, DNA and protein damage, inhibition of cell proliferation, and cell apoptosis. The findings from this work provide greater insight into the action of green synthesized Ag/AgCl NPs on the control of A. aegypti larvae.Entities:
Keywords: Aedes aegypti; Bacillus thuringiensis; crystal toxin; mechanism; proteomic; silver nanoparticle
Year: 2022 PMID: 35886817 PMCID: PMC9323952 DOI: 10.3390/insects13070641
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 3.139
Figure 1Expression of B. thuringiensis subsp. israelensis (Bti) toxins analyzed using SDS-PAGE (10% gel). Lane M: protein standard marker; lane 1: protein expression of Bti; lane 2: protein expression of E. coli harboring cry4Ba gene; lane 3: protein expression of E. coli harboring cry4Aa gene; lane 4: protein expression of E. coli JM109 harboring pUC12 (negative control). Whole protein lysate was extracted from ~107 cells. Arrows (<) indicate expression of Cry toxins in Bti; ◄ indicate heterologous expression of Cry toxins in E. coli.
Mosquito larvicidal activity of B. thuringiensis subsp. israelensis and E. coli expressing different Cry toxins against A. aegypti larvae.
| Bacterium | LC50 (Cells/mL) |
|---|---|
| 4.62 × 102 | |
| 1.20 × 106 | |
| 6.20 × 105 | |
| - |
Figure 2SEM images of silver/silver chloride nanoparticles (Ag/AgCl NPs) synthesized using (A) supernatant of Bti; (B) solubilized inclusion proteins of Bti (mix toxins); (C) solubilized Cry4Aa protein; (D) solubilized Cry4Ba protein.
Figure 3Energy-dispersive X-ray spectrometry spectra of Ag/AgCl NPs synthesized using (A) supernatant of Bti; (B) solubilized inclusion proteins of Bti (mix toxins); (C) solubilized Cry4Aa protein; (D) solubilized Cry4Ba protein.
Mosquitocidal activity of Ag/AgCl NPs synthesized using supernatant and solubilized inclusion proteins of Bti against A. aegypti larvae.
| Source of AgNPs | LC50 (µg/mL) | LC90 (µg/mL) (LCL-UCL) |
|---|---|---|
| Supernatant of | 0.133 (0.089–0.194) | 0.292 (0.222–0.446) |
| Inclusion proteins of | 0.206 (0.161–0.273) | 0.423 (0.338–0.591) |
| Cry4Aa protein | 0.148 (0.018–0.508) | 0.358 (0.219–2.020) |
| Cry4Ba protein | 0.217 (0.137–0.423) | 0.415 (0.286–0.985) |
LCL: lower confidence limits; UCL: upper confidence limits.
Figure 4Silver-stained 2D gel images of midgut proteins: (A) control group treated with ddH2O; (B) group treated with concentration at LC25 of Ag/AgCl NPs synthesized using supernatant of Bti. Numbered spots are differentially expressed proteins that were selected for identification using LC-MS. Positions of molecular size markers (in kDa) are indicated on the left and the pH range of isoelectric focusing on the bottom.
Identification of differentially regulated proteins between control (ddH2O) and Ag/AgCl NP treatment groups. Database searches using the Mascot program against A. aegypti protein database.
| Spot Number a | Top Match Protein | Accession Number b | Predicted Mass (kDa) | Peptide Match | Expression c |
|---|---|---|---|---|---|
|
| |||||
| 1 | Myosin I heavy chain isoform X1 | 1218220707 | 276.3 | 14 | ↑ |
| 9 | Tau and MAP protein, tubulin-binding repeat | 108871405 | 31.7 | 9 | ↑ |
| 13 | Microtubule-associated protein | 1218209813 | 150.4 | 9 | ↑ |
|
| |||||
| 3 | Heat shock 70-kDa protein 4 isoform X1 | 1218258666 | 94.0 | 9 | ↑ |
| 12 | Heat shock 70-kDa protein 4 isoform X2 | 1218258668 | 91.1 | 9 | ↑ |
|
| |||||
| 6 | F0F1-type ATP synthase beta subunit | 94468834 | 54.0 | 12 | ↑ |
|
| |||||
| 5 | Condensin complex subunit 3 | 1218229275 | 170.5 | 9 | ↑ |
| 14 | Methyltransferase | 108880940 | 113.2 | 9 | ↑ |
|
| |||||
| 4 | Zinc finger C2HC domain-containing protein 1C isoform X1 | 1218219689 | 58.8 | 9 | ↑ |
|
| |||||
| 11 | Lectizyme | 157124382 | 31.4 | 8 | ↑ |
|
| |||||
| 15 | Protein tyrosine kinases | 403182426 | 123.5 | 9 | ↑ |
|
| |||||
| 8 | Amiloride-sensitive sodium channel | 108869271 | 54.0 | 9 | ↑ |
|
| |||||
| 2 | Putative leucine rich repeat some | 943361693 | 110.3 | 9 | ↓ |
| 10 | Uncharacterized protein | 1218249106 | 86.8 | 9 | ↑ |
| 7 | Serine-rich protein | 108879398 | 62.7 | 9 | ↑ |
a Spot number as shown in Figure 4; b protein in the NCBI database for which significant peptide mass matches; c upregulated expression “↑”; downregulated expression “↓”.